Booz Allen

Booz Allen Acquires Tracepoint, Bolstering Market Leadership in Cybersecurity

Retrieved on: 
Monday, September 13, 2021

Booz Allen exercised its option to acquire the remainder of Tracepoints business after making an initial strategic investment in Tracepoint in January 2021.

Key Points: 
  • Booz Allen exercised its option to acquire the remainder of Tracepoints business after making an initial strategic investment in Tracepoint in January 2021.
  • This transaction is part of a broader capital deployment strategy to accelerate Booz Allens entry and advancement in critical technology areas.
  • Booz Allen retained Goldman Sachs & Co LLC as financial advisor for the transaction and King & Spalding LLP as legal advisor.
  • For more than 100 years, military, government, and business leaders have turned to Booz Allen Hamilton to solve their most complex problems.

MDIC Selects Booz Allen Hamilton to Support its Medical Device Cybersecurity Benchmarking Initiative

Retrieved on: 
Monday, May 17, 2021

b'The Medical Device Innovation Consortium (MDIC) today announced a partnership with Booz Allen Hamilton to establish a benchmark of the medical device industry\xe2\x80\x99s cybersecurity maturity and create resources to measure maturity over time.

Key Points: 
  • b'The Medical Device Innovation Consortium (MDIC) today announced a partnership with Booz Allen Hamilton to establish a benchmark of the medical device industry\xe2\x80\x99s cybersecurity maturity and create resources to measure maturity over time.
  • The goal of the Medical Device Cybersecurity Benchmarking Initiative is to measure cybersecurity maturity and benchmark across the industry to drive common improvements that reduce overall cybersecurity risk.\n\xe2\x80\x9cBoth the technical solution and the programmatic structure proposed by the Booz Allen Hamilton team is well aligned with the cybersecurity vision of MDIC and its stakeholders.
  • Booz Allen is committed to maximizing patient safety and the healthcare sector\xe2\x80\x99s resiliency through innovations in technology and security,\xe2\x80\x9d said Kelly Rozumalski, who leads Booz Allen\xe2\x80\x99s secure connected health initiatives and health cybersecurity portfolio across the defense, federal and commercial markets.\n\xe2\x80\x9cAs part of the FDA\xe2\x80\x99s ongoing commitment to strengthening medical device cybersecurity, we are pleased to support MDIC\xe2\x80\x99s Medical Device Cybersecurity Benchmarking Initiative.
  • The JSP \xe2\x80\x93 an initiative co-led by FDA with the medical device industry and healthcare delivery organizations - articulates a total product lifecycle approach to medical device cybersecurity.

Securonix Powers Booz Allen’s New Cloud-Based SIEM as a Service

Retrieved on: 
Thursday, May 14, 2020

Leveraging Securonixs Next-Gen SIEM, clients of Booz Allens SIEM as a Service will benefit from increased visibility across their threat landscape and a single point of management for analytics, user behavior, threat detection, threat intelligence, and threat modeling.

Key Points: 
  • Leveraging Securonixs Next-Gen SIEM, clients of Booz Allens SIEM as a Service will benefit from increased visibility across their threat landscape and a single point of management for analytics, user behavior, threat detection, threat intelligence, and threat modeling.
  • We designed Booz Allen SIEM as a Service to focus on outcomes: greater coverage, faster mean-time-to-detect and mean-time-to-respond, migration from signature-based detection to pattern-based detections, ease of integrations, as well as many others.
  • Securonix Next-Gen SIEM offers the scale, real-time data enrichment, advanced analytics and intelligent response capabilities that helps deliver on that vision.
  • Securonix Next-Gen SIEM delivers scalability, threat detection and response, cost-effectiveness, and ease of management thats perfectly complemented by Booz Allens expertise.

Booz Allen Hamilton and Medallia Form Strategic Alliance to Revolutionize Government Experience

Retrieved on: 
Wednesday, November 20, 2019

Medallia (NYSE: MDLA) today announced a strategic partnership with Booz Allen Hamilton (NYSE: BAH) that fuses Booz Allens Experience Management consulting expertise and implementation services with Medallias award-winning Customer Experience Management platform, the Medallia Experience Cloud.

Key Points: 
  • Medallia (NYSE: MDLA) today announced a strategic partnership with Booz Allen Hamilton (NYSE: BAH) that fuses Booz Allens Experience Management consulting expertise and implementation services with Medallias award-winning Customer Experience Management platform, the Medallia Experience Cloud.
  • The strategic partnership with Medallia will take Booz Allens CX capability and build that expertise within the Medallia Experience Cloud platform to deliver experience management programs tailored to the public sector.
  • Visit Medallia in person at the D.C. City Tour on December 12, 2019 where Booz Allen Hamilton will be speaking.
  • For more than 100 years, military, government, and business leaders have turned to Booz Allen Hamilton to solve their most complex problems.